Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Irbesartan 75 mg, 150 mg, 300 mg Tablets Bristol-Myers Squibb Company, Evansville, Indiana, United States of America and Sanofi Winthrop Industrie, Ambares France Avapro Amoxycillin trihydrate equivalent to 125 mg, 250 mg, 375 mg, 500 mg, 750 mg, 1000 mg amoxycillin Tablets, soluble Yamanouchi Europe BV., Meppel, The Netherlands Flemoxin Solutab Gemfibrozil 300 mg Capsule, powder filled Genpharm Inc Pharmaceuticals, Etobicoke, Ontario, Canada Gemizol Cerivastatin sodium 0.1 mg, 0.2 mg, 0.3 mg Tablets, film coated Bayer AG., Leverkusen, Germany Lipobay Dated this 25th day of May 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.